Restricted Eating Time in the Treatment of Type 2 Diabetes
ConditionType 2 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSteno Diabetes Center Copenhagen
About this trial
The overall aim of the present study is to investigate the effectiveness of implementing a 1-year time-restricted eating (TRE)-based intervention on glycaemic control, body weight and composition, cardiometabolic risk factors, and behaviour in individuals with overweight/obesity and type 2 diabetes (T2D).
Eligibility criteria
Qualifiers
Age: ≥18 years
Overweight or obesity (BMI ≥25 kg/m2)
T2D with HbA1c>53 mmol/mol
Habitual eating window ≥12 h/day (incl. foods/snacks and energy-containing beverages)
Disqualifiers
Bariatric surgery or planned bariatric surgery within study duration
Use of fast acting insulin and combination insulin products
Habitual CGM use
A wish to adhere to Ramadan
Trial design
Treatments tested in this trial
- Time restricted eating
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Steno Diabetes Center Copenhagen
Lead sponsor
University of Leeds
Collaborator
Salk Institute for Biological Studies
Collaborator
University of Copenhagen
Collaborator
Glostrup University Hospital, Copenhagen
Collaborator
Source ClinicalTrials.gov